Targeting self and neo-epitopes with a modular self-adjuvanting cancer vaccine
Belnoue E, Mayol JF, Carboni S, Di Berardino Besson W, Dupuychaffray E, Nelde A, Stevanovic S, Santiago-Raber ML, Walker PR, Derouazi M.
JCI Insight. 2019 Apr;4(11):e127305

Mechanistic insights into the efficacy of cell penetrating peptide-based cancer vaccines
Grau M, Walker PR, Derouazi M
Cell Mol Life Sci. 2018 Mar;75(16): 2887-2896

Enhancing anti-tumor immune responses by optimized combinations of cell-penetrating peptide based-vaccines and adjuvants
Belnoue E, Di Berardino-Besson W, Gaertner H, Carboni S, Dunand-Sauthier I, Cerini F, Suso-Inderberg EM, Wälchli S, König S, Salazar AM, Hartley O, Dietrich PY, Walker PR and Derouazi M.
Mol Ther. 2016 Sep;24(9):1675-85

Cell-penetrating peptides – the Swiss Army knife of cancer vaccines
Walker PR, Belnoue E, Dietrich PY, Derouazi M.
Oncoimmunology. 2016 Mar; 5(3): e1095435

Novel Cell-Penetrating Peptide-Based Vaccine Induces Robust CD4+ and CD8+ T Cell-Mediated Antitumor Immunity
Derouazi M, Di Berardino-Besson W, Belnoue E, Hoepner S, Walther R, Benkhoucha M, Teta P, Dufour Y, Yacoub Maroun C, Salazar AM, Martinvalet D, Dietrich PY, Walker PR.
Cancer Res. 2015 Aug 1;75(15):3020-31

Synergy between CD8 T cells and Th1 or Th2 polarised CD4 T cells for adoptive immunotherapy of brain tumours
Hoepner S, Loh JM, Riccadonna C, Derouazi M, Maroun CY, Dietrich PY, Walker PR.
PLoS One. 2013 May 23;8(5):e63933

Immune infiltration of spontaneous mouse astrocytomas is dominated by immunosuppressive cells from early stages of tumor development
Tran Thang NN, Derouazi M, Philippin G, Arcidiaco S, Di Berardino-Besson W, Masson F, Hoepner S, Riccadonna C, Burkhardt K, Guha A, Dietrich PY, Walker PR.
Cancer Res. 2010 Jun 15;70(12):4829-39